ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,407Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 288

$597K Total Retail Price of All Prescriptions

Rank: 44 out of 288

557 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 557 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 557 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 8,538 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 547 464 1 1
HYDROCODONE-ACETAMINOPHEN 495 357 S3 2 7
LEVOTHYROXINE SODIUM 428 402 3 2
FUROSEMIDE 367 328 4 5
AMLODIPINE BESYLATE 336 317 5 6
OMEPRAZOLE 297 234 6 3
ZOLPIDEM TARTRATE 272 240 7 22
METOPROLOL TARTRATE 197 192 8 8
CITALOPRAM HBR 180 158 9 18
ATORVASTATIN CALCIUM 158 145 10 14
PRAVASTATIN SODIUM 156 156 11 21
POTASSIUM CHLORIDE 151 123 12 11
METFORMIN HCL 140 101 13 12
LISINOPRIL 139 103 14 4
GABAPENTIN 139 71 14 17
FENOFIBRATE 127 100 16 61
CYMBALTA 126 94 17 67
DONEPEZIL HCL 118 112 18 29
WARFARIN SODIUM 113 105 19 9
ATENOLOL 112 82 20 10
PANTOPRAZOLE SODIUM 110 89 21 42
TAMSULOSIN HCL 109 93 22 24
BENAZEPRIL HCL 100 88 23 52
OXAPROZIN 95 83 24 290
GLIPIZIDE 90 78 25 56
HYDROCHLOROTHIAZIDE 90 61 25 13
AMLODIPINE BESYLATE-BENAZEPRIL 90 68 25 89
METOPROLOL SUCCINATE 86 68 28 15
CLONIDINE HCL 84 84 29 70
TRAZODONE HCL 81 65 30 37
LEVOFLOXACIN 78 65 31 80
NEXIUM 74 59 32 43
ISOSORBIDE MONONITRATE ER 73 73 33 35
PROAIR HFA 72 54 34 45
ROPINIROLE HCL 71 60 35 74
POLYETHYLENE GLYCOL 3350 68 21 36 38
JANUVIA 67 53 37 88
BISOPROLOL-HYDROCHLOROTHIAZIDE 67 58 37 158
SPIRIVA 65 50 39 48
TRIAMTERENE-HCTZ 65 44 39 28
OXYCONTIN 65 16 S2 39 182
LOSARTAN POTASSIUM 62 60 42 16
PEN NEEDLE 61 43 43 100
DOXAZOSIN MESYLATE 58 49 44 78
GLYBURIDE 53 49 R 45 59
GLYBURIDE-METFORMIN HCL 52 42 R 46 164
LANTUS SOLOSTAR 52 40 46 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.